Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Cathepsin Activatable Fluorescent Probe (LUM015)

This study has been completed.
American Society of Clinical Oncology
Information provided by (Responsible Party):
David Kirsch, Duke University Medical Center Identifier:
First received: June 20, 2012
Last updated: December 8, 2015
Last verified: December 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2015
  Primary Completion Date: August 2014 (Final data collection date for primary outcome measure)